Danish pharmaceuticals company Novo Nordisk has asked its fully-owned IT subsidiary NNIT to study the possibility of a separate listing on the Copenhagen stock exchange, company officials told Reuters on Wednesday. "We don't think Novo Nordisk are the best owners, and that's why we are looking to see if we can find new co-owners," said Jesper Brandgaard, chief financial officer at Novo Nordisk and chairman of NNIT. "Novo Nordisk's main activity is to sell pharmaceutical products, which is not a main activity for us," he said.
Help employers find you! Check out all the jobs and post your resume.
